Precision treatment for depression using biomarkers
Part of Mental health clinical trials.
This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with major depressive disorder (MDD).
- Your depression is moderate to severe (score of 17 or higher on a standard depression scale).
- You do not have other psychiatric conditions like bipolar disorder or schizophrenia.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have serious physical illnesses or substance abuse problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.
This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.
This study uses a blood test (biomarker) to help pick the antidepressant that might work best for you. It compares two treatments—standard antidepressants and ketamine—in people with major depression who haven't gotten enough relief from one prior treatment.
This trial tests whether a pharmacist can use your genetic information to better manage your depression medications. It may help find the right drug or dose for you.
This trial tests whether using a website plus your genetic information helps doctors pick a better antidepressant for you. It aims to improve treatment for people with depression.
This study tests whether doing genetic testing before starting or adjusting antidepressants—guided by a pharmacist—can improve treatment for people with moderate to severe depression. The goal is to help match you with antidepressants more safely and effectively.
Hear when a new Depression - Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.